SANOFI: Strong Q2 2026 profit and sales growth driven by diabetes and operational excellenceQuartr·5 hours agoSNY-0.63%
Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&Dbenzinga_article·Jul 30 at 01:45 PMSNY-0.63%
Sanofi shares slide after CEO signals challenges to fill drug pipelineMSN·Jul 30 at 10:04 AMSNY-0.63%
Sanofi Q2 FY26 business EPS rises 33.3% to €2.09; net sales climb 17.8% to €11.6 billionPUBT·Jul 30 at 12:31 AMSNY-0.63%
